Fire1
Ireland - DublinBiotechnology
Focus: Fire1 is a Dublin-based biotechnology company focused on heart failure monitoring through proprietary device systems. The company operates in the cardiovascular and metabolic disease space with a specialized, early-stage portfolio.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Fire1
AI assessmentNot HiringNo open roles listed right now. Follow Fire1 to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
FIRE1 System
Heart FailureClinical Trials (1)
NCT04203576First in Human Clinical Investigation of the FIRE1 System in Heart Failure Patients (FUTURE-HF)
N/AHelp build intelligence for Fire1
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.